The global eye health supplements market size is anticipated to reach USD 2.94 billion by 2030 and is anticipated to expand at a CAGR of 7.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising elderly population, growing exposure to blue light, and increasing prevalence of various vision disorders such as macular degeneration, refractive errors, cataract, inflammation, diabetic retinopathy, corneal opacity, trachoma, and dry eye syndrome are the major factors driving the market. In addition, uneven quality of eye care services, workforce shortages, lifestyle changes leading to less time spent outdoors, poor nutritional habits and dropping food quality, and increasing awareness regarding eye health is further boosting the market growth.
In addition, the widespread use of digital devices has contributed to a rise in digital eye strain. Extended screen time exposes individuals to blue light, which can lead to discomfort and potential long-term effects on vision. This has heightened awareness about the importance of eye health, prompting consumers to seek supplements containing ingredients like lutein and zeaxanthin, known for their potential to filter injurious blue light and support retinal health.
The availability of a wide range of eye health supplements through various distribution channels, including e-commerce platforms, has made these products more accessible globally. This accessibility, combined with effective marketing strategies, has contributed to increased consumer awareness and adoption of eye health supplements. Additionally, rising healthcare expenditures, particularly on preventive care, have driven the demand for eye health supplements, as consumers are willing to invest in products that help maintain their eye health and prevent vision problems.
Request a free sample copy or view report summary: Eye Health Supplements Market Report
Lutein & zeaxanthin ingredients dominated the ingredient type segment with the largest revenue share of 33.4% in 2024, driven by the growing occurrence of eye disorders, mainly AMD.
Alpha-Lipoic Acid (ALA) is expected to grow at a CAGR of 8.3% over the forecast period, attributed to its efficiency in fighting age-related eye conditions, such as cataracts and macular degeneration.
Age-related Macular Degeneration (AMD) led the market and held the largest revenue share of 32.2% in 2024, as it impacts the macula, the central region of the retina responsible for sharp, central vision.
The inflammation is expected to grow at a lucrative CAGR of 10.7% over the forecast period, owing to increased pollution, screen time, and aging.
The tablets segment dominated the global eye health supplements market and accounted for the largest revenue share in 2024. Capsules are expected to grow at a CAGR of 6.9% from 2025 to 2030.
NorthAmerica dominated the global eye health supplements market with the largest revenue share in 2024. This was primarily driven by the rising occurrence of chronic eye conditions, specifically age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, and dry eye syndrome.
In May 2024, HealthyCell launched Eye Health, an ultra-absorbable gel supplement designed to support vision and retinal health. Formulated with nutrients like lutein, zeaxanthin, astaxanthin, lycopene, vitamins A and E, and zinc, it aims to promote visual acuity and protect against oxidative stress.
Grand View Research has segmented the global eye health supplements market on the basis of ingredient type, indication, formulation, and region:
Eye Health Supplements Ingredient Type Outlook (Revenue, USD Million, 2018 - 2030)
Lutein and Zeaxanthin
Antioxidants
Omega-3 Fatty acids
Flavonoids
Alpha-Lipoic Acid
Coenzyme Q10
Astaxanthin
Others
Eye Health Supplements Indication Outlook (Revenue, USD Million, 2018 - 2030)
Age-related Macular Degeneration (AMD)
Dry Eye Syndrome
Inflammation
Cataract
Others
Eye Health Supplements Formulation Outlook (Revenue, USD Million, 2018 - 2030)
Tablets
Capsules
Liquid
Softgels
Powder
Others
Eye Health Supplements Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Eye Health Supplements Market
The Nature's Bounty Co.
Vitabiotics Ltd.
Pfizer Inc
Amway International
Bausch & Lomb
Nutrivein
ZeaVision LLC
Kemin Industries, Inc.
EyeScience
Nutrachamps
"The quality of research they have done for us has been excellent..."